Allergy Therapeutics stunned investors this month with the failure of a pivotal trial for its subcutaneous allergen immunotherapy product, Pollinex...
Read More...
The post Likelihood that Allergy Therapeutics’ trial for PQ Birch was a hidden success is low appeared first on Pharmaceutical Technology.